Wedbush Securities’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-11,000
| Closed | -$25K | – | 930 |
|
|
2017
Q4 | $25K | Buy |
+11,000
| New | +$25K | ﹤0.01% | 840 |
|
|
2017
Q2 | – | Sell |
-18,698
| Closed | -$64K | – | 908 |
|
|
2017
Q1 | $64K | Buy |
+18,698
| New | +$64K | 0.01% | 792 |
|
|
2016
Q4 | – | Sell |
-15,000
| Closed | -$64K | – | 920 |
|
|
2016
Q3 | $64K | Sell |
15,000
-4,500
| -23% | -$19.2K | 0.01% | 776 |
|
|
2016
Q2 | $47K | Buy |
19,500
+6,000
| +44% | +$14.5K | 0.01% | 733 |
|
|
2016
Q1 | $63K | Sell |
13,500
-3,033
| -18% | -$14.2K | 0.01% | 687 |
|
|
2015
Q4 | $65K | Buy |
16,533
+3,500
| +27% | +$13.8K | 0.01% | 672 |
|
|
2015
Q3 | $50K | Buy |
13,033
+2,000
| +18% | +$7.67K | 0.01% | 665 |
|
|
2015
Q2 | $51K | Buy |
+11,033
| New | +$51K | 0.01% | 688 |
|